Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1777 to 1826 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5386.37\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5744.89\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06656\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 2 (actin-related protein 2). [source:swissprot;acc:o15142]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to actin-related protein 3-beta. [source:sptrembl;acc:q96bt2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-related protein 2/3 complex subunit 1a (sop2-like protein). [source:swissprot;acc:q92747]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interferon-related developmental regulator 2 (skmc15 protein). [source:swissprot;acc:q12894]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 16 kda subunit (p16-arc) (actin-related protein 2/3 complex subunit 5). [source:swissprot;acc:o15511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 12 (ec 2.7.1.37) (aurora- and ipl1- like midbody-associated protein 1) (aim-1) (aurora/ipl1-related kinase 2) (aurora-related kinase 2) (stk-1) (aurora-b). [source:swissprot;acc:q96gd4]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5839.72\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6227.33\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 13 (ec 2.7.1.37) (aurora/ipl1/eg2 protein 2) (aurora/ipl1-related kinase 3) (aurora-c). [source:swissprot;acc:q9uqb9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine kinase 6 (ec 2.7.1.37) (serine/threonine kinase 15) (aurora/ipl1-related kinase 1) (aurora-related kinase 1) (hark1) (aurora-a) (breast-tumor-amplified kinase). [source:swissprot;acc:o14965]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 2 isoform b; eps15 binding protein. [source:refseq;acc:nm\_014964]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5948.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6342.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06634\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases iii 12.5 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c11 subunit) (hsc11p) (hrpc11) (my010 protein). [source:swissprot;acc:q9y2y1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5501.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5866.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0663\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin tyrosine ligase-like protein hottl (hqp0207). [source:swissprot;acc:q9y4r7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5387.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5743.5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06605\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
valyl-trna synthetase 2 (ec 6.1.1.9) (valine--trna ligase 2) (valrs 2) (g7a). [source:swissprot;acc:p26640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5096.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5432.63\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3618.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3394.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06591\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b beta subunit (eif-2b gdp-gtp exchange factor) (s20i15) (s20iii15). [source:swissprot;acc:p49770]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5456.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5816.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b delta subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9ui10]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5424.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5781.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06587\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5881.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6268.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06584\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymidylate synthase (ec 2.1.1.45) (ts) (tsase). [source:swissprot;acc:p04818]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4980.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5307.81\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06571\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2 precursor (sdf-2). [source:swissprot;acc:q99470]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2-like protein 1 precursor (sdf2 like protein 1) (pwp1-interacting protein 8). [source:swissprot;acc:q9hcn8]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate kinase, m1 isozyme (ec 2.7.1.40) (pyruvate kinase muscle isozyme) (cytosolic thyroid hormone-binding protein) (cthbp) (thbp1). [source:swissprot;acc:p14618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4783.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5097.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
endothelial-derived gene 1. [source:refseq;acc:nm\_025205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6399.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6818.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4941.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5265.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06539\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 3. [source:refseq;acc:nm\_017957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5816.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6196.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
colorectal mutant cancer protein (mcc protein). [source:swissprot;acc:p23508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6520.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6946.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7659.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8156.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1812\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hrd1 protein isoform a; synoviolin1. [source:refseq;acc:nm\_032431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5514.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5871.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06482\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5866.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06464\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-beta (hsp 84) (hsp 90). [source:swissprot;acc:p08238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5733.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06463\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6104.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6498.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shc transforming protein. [source:swissprot;acc:p29353]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 289, id1 regulated; likely ortholog of mouse zfp289. [source:refseq;acc:nm\_032389]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal shc. [source:refseq;acc:nm\_016848]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 1. [source:swissprot;acc:p32889]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a1 (helix-destabilizing protein) (single-strand binding protein) (hnrnp core protein a1). [source:swissprot;acc:p09651]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 3. [source:swissprot;acc:p16587]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/